Nabilone for Agitation in Frontotemporal Dementia

Summary

The primary goal of this study is to test the hypothesis that oral nabilone treatment will reduce agitation compared with placebo in patients with Frontotemporal Dementia (both behavioural variant frontotemporal dementia and primary progressive aphasia). The study population is defined as patients with probable Frontotemporal Dementia that meet the International Psychogeriatric Association criteria for agitation in cognitive disorders.

Timeline

Start

2023-03-07

Primary completion

2026-04

Completion

2026-05

Drugs

Indications